AAAAAA
Results:
1-19
|
Results: 19
Authors:
Waterer, GW
Quasney, MW
Cantor, RM
Wunderink, RG
Citation: Gw. Waterer et al., Septic shock and respiratory failure in community-acquired pneumonia have different TNF polymorphism associations, AM J R CRIT, 163(7), 2001, pp. 1599-1604
Authors:
Rubinstein, E
Cammarata, SK
Oliphant, TH
Wunderink, RG
Citation: E. Rubinstein et al., Linezolid (PNU-100766) versus vancomycin in the treatment of hospitalized patients with nosocomial pneumonia: A randomized, double-blind, multicenterstudy, CLIN INF D, 32(3), 2001, pp. 402-412
Authors:
Waterer, GW
Wunderink, RG
Citation: Gw. Waterer et Rg. Wunderink, The influence of the severity of community-acquired pneumonia on the usefulness of blood cultures, RESP MED, 95(1), 2001, pp. 78-82
Authors:
Waterer, GW
Wunderink, RG
Citation: Gw. Waterer et Rg. Wunderink, Increasing threat of Gram-negative bacteria, CRIT CARE M, 29(4), 2001, pp. N75-N81
Authors:
Waterer, GW
Wunderink, RG
Citation: Gw. Waterer et Rg. Wunderink, Controversies in the diagnosis of ventilator-acquired pneumonia, MED CLIN NA, 85(6), 2001, pp. 1565
Authors:
Wunderink, RG
Waterer, GW
Citation: Rg. Wunderink et Gw. Waterer, Severe community-acquired pneumonia - The need to customize empiric therapy, CHEST, 120(4), 2001, pp. 1053-1055
Authors:
Wunderink, RG
Leeper, KV
Schein, R
Nelson, S
DeBoisblanc, BP
Fotheringham, N
Logan, E
Citation: Rg. Wunderink et al., Filgrastim in patients with pneumonia and severe sepsis or septic shock, CHEST, 119(2), 2001, pp. 523-529
Authors:
Wunderink, RG
Waterer, GW
Citation: Rg. Wunderink et Gw. Waterer, Appropriate microbiological testing in community-acquired pneumonia, CHEST, 119(1), 2001, pp. 5-7
Authors:
Waterer, GW
Somes, GW
Wunderink, RG
Citation: Gw. Waterer et al., Monotherapy may be suboptimal for severe bacteremic pneumococcal pneumonia, ARCH IN MED, 161(15), 2001, pp. 1837-1842
Authors:
Waterer, GW
Baselski, VS
Wunderink, RG
Citation: Gw. Waterer et al., Legionella and community-acquired pneumonia: A review of current diagnostic tests from a clinician's viewpoint, AM J MED, 110(1), 2001, pp. 41-48
Authors:
Waterer, GW
Wan, JY
Kritchevsky, SB
Wunderink, RG
Satterfield, S
Bauer, DC
Newman, AB
Taaffe, DR
Jensen, RL
Crapo, RO
Citation: Gw. Waterer et al., Airflow limitation is underrecognized in well-functioning older people, J AM GER SO, 49(8), 2001, pp. 1032-1038
Authors:
Waterer, GW
Wunderink, RG
Winer-Muram, HT
Citation: Gw. Waterer et al., Bronchostenosis due to childhood tuberculosis and manifested as an asymptomatic mass, SOUTH MED J, 93(11), 2000, pp. 1102-1104
Authors:
Waterer, GW
Wunderink, RG
Jones, CB
Citation: Gw. Waterer et al., Fatal pneumococcal pneumonia attributed to macrolide resistance and azithromycin monotherapy, CHEST, 118(6), 2000, pp. 1839-1840
Authors:
Wunderink, RG
Citation: Rg. Wunderink, Radiologic diagnosis of ventilator-associated pneumonia, CHEST, 117(4), 2000, pp. 188S-190S
Authors:
Wunderink, RG
Citation: Rg. Wunderink, Clinical criteria in the diagnosis of ventilator-associated pneumonia, CHEST, 117(4), 2000, pp. 191S-194S
Authors:
Waterer, GW
Jones, CB
Wunderink, RG
Citation: Gw. Waterer et al., Bacteremic community-acquired pneumonia in an immunocompetent adult due toBurkholderia cepacia, CHEST, 116(6), 1999, pp. 1842-1843
Authors:
Wunderink, RG
Citation: Rg. Wunderink, Prevention of ventilator-associated pneumonia - Does one size fit all?, CHEST, 116(5), 1999, pp. 1155-1156
Authors:
Waterer, GW
Jennings, SG
Wunderink, RG
Citation: Gw. Waterer et al., The impact of blood cultures on antibiotic therapy in pneumococcal pneumonia, CHEST, 116(5), 1999, pp. 1278-1281
Authors:
George, DL
Falk, PS
Wunderink, RG
Leeper, KV
Meduri, GU
Steere, EL
Corbett, CE
Mayhall, CG
Citation: Dl. George et al., Epidemiology of ventilator-acquired pneumonia based on protected bronchoscopic sampling, AM J R CRIT, 158(6), 1998, pp. 1839-1847
Risultati:
1-19
|